1. Home
  2. WRN vs NGNE Comparison

WRN vs NGNE Comparison

Compare WRN & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WRN
  • NGNE
  • Stock Information
  • Founded
  • WRN 2006
  • NGNE 2003
  • Country
  • WRN Canada
  • NGNE United States
  • Employees
  • WRN N/A
  • NGNE N/A
  • Industry
  • WRN Metal Mining
  • NGNE Biotechnology: Pharmaceutical Preparations
  • Sector
  • WRN Basic Materials
  • NGNE Health Care
  • Exchange
  • WRN Nasdaq
  • NGNE Nasdaq
  • Market Cap
  • WRN 196.9M
  • NGNE 230.0M
  • IPO Year
  • WRN N/A
  • NGNE N/A
  • Fundamental
  • Price
  • WRN $1.01
  • NGNE $18.08
  • Analyst Decision
  • WRN Strong Buy
  • NGNE Strong Buy
  • Analyst Count
  • WRN 1
  • NGNE 6
  • Target Price
  • WRN $4.25
  • NGNE $60.80
  • AVG Volume (30 Days)
  • WRN 267.1K
  • NGNE 214.1K
  • Earning Date
  • WRN 03-28-2025
  • NGNE 11-18-2024
  • Dividend Yield
  • WRN N/A
  • NGNE N/A
  • EPS Growth
  • WRN N/A
  • NGNE N/A
  • EPS
  • WRN N/A
  • NGNE N/A
  • Revenue
  • WRN N/A
  • NGNE $925,000.00
  • Revenue This Year
  • WRN N/A
  • NGNE N/A
  • Revenue Next Year
  • WRN N/A
  • NGNE N/A
  • P/E Ratio
  • WRN N/A
  • NGNE N/A
  • Revenue Growth
  • WRN N/A
  • NGNE N/A
  • 52 Week Low
  • WRN $0.95
  • NGNE $14.42
  • 52 Week High
  • WRN $1.66
  • NGNE $74.49
  • Technical
  • Relative Strength Index (RSI)
  • WRN 43.91
  • NGNE 46.03
  • Support Level
  • WRN $1.00
  • NGNE $15.16
  • Resistance Level
  • WRN $1.05
  • NGNE $16.70
  • Average True Range (ATR)
  • WRN 0.04
  • NGNE 1.18
  • MACD
  • WRN -0.00
  • NGNE 0.45
  • Stochastic Oscillator
  • WRN 22.22
  • NGNE 77.44

About WRN Western Copper and Gold Corporation

Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).

About NGNE Neurogene Inc.

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Share on Social Networks: